Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole plus misoprostol versus misoprostol alone for retained products of pregnancy after legal abortion
IRCT20250505065609N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Oct 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in retained placenta comparing Letrozole + misoprostol with Misoprostol alone (2 arms). Primary endpoints: Duration of abortion and Type of abortion. Started Oct 2025; status: completed.
02
Drugs
letrozolemisoprostol
03
Conditions
retained placenta
Beyond the preview
Go deeper on IRCT20250505065609N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250505065609N1.